vs
Amphastar Pharmaceuticals, Inc.（AMPH）与六旗（FUN）财务数据对比。点击上方公司名可切换其他公司
六旗的季度营收约是Amphastar Pharmaceuticals, Inc.的1.2倍（$225.6M vs $183.1M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs -119.0%，领先132.4%），六旗同比增速更快（11.7% vs -1.8%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
六旗娱乐是总部位于美国北卡罗来纳州夏洛特的游乐园运营企业，由雪松会与原六旗公司于2024年7月1日对等合并而成，是全球最大的区域性游乐园运营商。旗下共运营42个场地，包含27座游乐园、15座水上乐园，配套9处 onsite 度假物业。
AMPH vs FUN — 直观对比
营收规模更大
FUN
是对方的1.2倍
$183.1M
营收增速更快
FUN
高出13.5%
-1.8%
净利率更高
AMPH
高出132.4%
-119.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $225.6M |
| 净利润 | $24.4M | $-268.6M |
| 毛利率 | 46.8% | — |
| 营业利润率 | 19.4% | — |
| 净利率 | 13.3% | -119.0% |
| 营收同比 | -1.8% | 11.7% |
| 净利润同比 | -35.7% | -22.2% |
| 每股收益（稀释后） | $0.51 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHFUN
| Q1 26 | — | $225.6M | ||
| Q4 25 | $183.1M | $650.1M | ||
| Q3 25 | $191.8M | $1.3B | ||
| Q2 25 | $174.4M | $930.4M | ||
| Q1 25 | $170.5M | $202.1M | ||
| Q4 24 | $186.5M | — | ||
| Q3 24 | $191.2M | $1.3B | ||
| Q2 24 | $182.4M | $571.6M |
净利润AMPHFUN
| Q1 26 | — | $-268.6M | ||
| Q4 25 | $24.4M | $-92.4M | ||
| Q3 25 | $17.4M | $-1.2B | ||
| Q2 25 | $31.0M | $-99.6M | ||
| Q1 25 | $25.3M | $-219.7M | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $40.4M | $111.0M | ||
| Q2 24 | $37.9M | $55.6M |
毛利率AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 46.8% | 91.4% | ||
| Q3 25 | 51.4% | 91.6% | ||
| Q2 25 | 49.6% | 91.3% | ||
| Q1 25 | 50.0% | 89.3% | ||
| Q4 24 | 46.5% | — | ||
| Q3 24 | 53.3% | 91.9% | ||
| Q2 24 | 52.2% | 90.7% |
营业利润率AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | -3.8% | ||
| Q3 25 | 13.2% | -83.7% | ||
| Q2 25 | 24.2% | 8.0% | ||
| Q1 25 | 21.9% | -158.9% | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 29.8% | 19.5% | ||
| Q2 24 | 30.3% | 21.6% |
净利率AMPHFUN
| Q1 26 | — | -119.0% | ||
| Q4 25 | 13.3% | -14.2% | ||
| Q3 25 | 9.0% | -90.1% | ||
| Q2 25 | 17.8% | -10.7% | ||
| Q1 25 | 14.8% | -108.7% | ||
| Q4 24 | 20.4% | — | ||
| Q3 24 | 21.1% | 8.2% | ||
| Q2 24 | 20.8% | 9.7% |
每股收益（稀释后）AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | $0.51 | $-0.93 | ||
| Q3 25 | $0.37 | $-11.77 | ||
| Q2 25 | $0.64 | $-0.99 | ||
| Q1 25 | $0.51 | $-2.20 | ||
| Q4 24 | $0.74 | — | ||
| Q3 24 | $0.78 | $1.10 | ||
| Q2 24 | $0.73 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $116.5M |
| 总债务越低越好 | $608.7M | — |
| 股东权益账面价值 | $788.8M | $279.2M |
| 总资产 | $1.6B | $7.7B |
| 负债/权益比越低杠杆越低 | 0.77× | — |
8季度趋势，按日历期对齐
现金及短期投资AMPHFUN
| Q1 26 | — | $116.5M | ||
| Q4 25 | $282.8M | $91.1M | ||
| Q3 25 | $276.2M | $70.7M | ||
| Q2 25 | $231.8M | $107.4M | ||
| Q1 25 | $236.9M | $61.5M | ||
| Q4 24 | $221.6M | — | ||
| Q3 24 | $250.5M | $89.7M | ||
| Q2 24 | $217.8M | $52.9M |
总债务AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | $608.7M | $5.2B | ||
| Q3 25 | $608.6M | $5.0B | ||
| Q2 25 | $607.7M | $5.3B | ||
| Q1 25 | $603.9M | $5.0B | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | $4.6B | ||
| Q2 24 | $586.9M | $2.3B |
股东权益AMPHFUN
| Q1 26 | — | $279.2M | ||
| Q4 25 | $788.8M | $549.8M | ||
| Q3 25 | $776.7M | $614.3M | ||
| Q2 25 | $757.5M | $1.8B | ||
| Q1 25 | $751.3M | $1.8B | ||
| Q4 24 | $732.3M | — | ||
| Q3 24 | $727.7M | $2.3B | ||
| Q2 24 | $713.3M | — |
总资产AMPHFUN
| Q1 26 | — | $7.7B | ||
| Q4 25 | $1.6B | $7.8B | ||
| Q3 25 | $1.7B | $7.9B | ||
| Q2 25 | $1.6B | $9.5B | ||
| Q1 25 | $1.6B | $9.2B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.5B | $9.4B | ||
| Q2 24 | $1.5B | $2.3B |
负债/权益比AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 0.77× | 9.40× | ||
| Q3 25 | 0.78× | 8.16× | ||
| Q2 25 | 0.80× | 2.97× | ||
| Q1 25 | 0.80× | 2.75× | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | 1.95× | ||
| Q2 24 | 0.82× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | — |
| 自由现金流经营现金流 - 资本支出 | $24.6M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | 1.35× | — |
| 过去12个月自由现金流最近4个季度 | $121.2M | — |
8季度趋势，按日历期对齐
经营现金流AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | $32.9M | $-37.7M | ||
| Q3 25 | $52.6M | $356.2M | ||
| Q2 25 | $35.6M | $187.0M | ||
| Q1 25 | $35.1M | $-178.0M | ||
| Q4 24 | $29.0M | — | ||
| Q3 24 | $60.0M | $337.4M | ||
| Q2 24 | $69.1M | — |
自由现金流AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | $24.6M | $-109.3M | ||
| Q3 25 | $47.2M | $256.2M | ||
| Q2 25 | $25.0M | $18.8M | ||
| Q1 25 | $24.4M | $-318.0M | ||
| Q4 24 | $16.6M | — | ||
| Q3 24 | $46.2M | $227.7M | ||
| Q2 24 | $63.1M | — |
自由现金流率AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 13.4% | -16.8% | ||
| Q3 25 | 24.6% | 19.4% | ||
| Q2 25 | 14.3% | 2.0% | ||
| Q1 25 | 14.3% | -157.4% | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 24.1% | 16.9% | ||
| Q2 24 | 34.6% | — |
资本支出强度AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 4.5% | 11.0% | ||
| Q3 25 | 2.8% | 7.6% | ||
| Q2 25 | 6.1% | 18.1% | ||
| Q1 25 | 6.3% | 69.3% | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 7.2% | 8.1% | ||
| Q2 24 | 3.3% | — |
现金转化率AMPHFUN
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | — | ||
| Q3 25 | 3.03× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 1.48× | 3.04× | ||
| Q2 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
FUN
| In-park admissions revenues | $113.4M | 50% |
| In-park product revenues | $89.0M | 39% |
| Out-of-park revenues | $28.8M | 13% |
